Description
The anti-CASP8 (FPSDSWCYF) TCR (clone 121) Jurkat cell line is a stable cell line made from the anti-CASP8 TCR lentivirus. The recombinant Jurkat T cell was designed to predict the MOA of CASP8-TCR, measure the CASP8-TCR specificity and screen target cells expressing CASP8. And the product can be used to treat Head-and-neck cancer